机译:Cox模型如何在患者水平的汇总数据集中对研究特定混杂因素做出反应:除非基线风险不同,随机效应更好地应对整个试验中的协变量不平衡
Cardiovasc Res Fdn, New York, NY 10019 USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden;
Cardiovasc Res Fdn, New York, NY 10019 USA;
Cardiovasc Res Fdn, New York, NY 10019 USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Hadassah Med Ctr, Jerusalem, Israel;
Cardiovasc Res Fdn, New York, NY 10019 USA|Hadassah Med Ctr, Jerusalem, Israel;
Cardiovasc Res Fdn, New York, NY 10019 USA|Columbia Univ, Med Ctr, New York, NY USA;
Cardiovasc Res Fdn, New York, NY 10019 USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Columbia Univ, Med Ctr, New York, NY USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Columbia Univ, Med Ctr, New York, NY USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Columbia Univ, Med Ctr, New York, NY USA;
Cardiovasc Res Fdn, New York, NY 10019 USA|Columbia Univ, Med Ctr, New York, NY USA;
Bassett Res Inst, Cooperstown, NY USA;
Cox proportional hazards; frailty; fixed effects; random effects; pooling data;
机译:Cox模型如何在患者级汇总数据集中对特定于学习的混淆作出反应:随机效果更好地应对跨试验的不平衡的协变量,除非基线危险不同
机译:使用Cox比例风险模型和基于非参数随机化的协方差分析估算随机临床试验中经协变量调整的对数风险比
机译:纤维蛋白溶解后早期的常规侵入性管理:在7项随机对照试验的汇总患者水平分析中,基线风险与治疗效果之间的关系
机译:使用比例风险模型确定协变量对汇总数据的影响—案例研究
机译:在临床试验数据中测量连续基线协变量失衡
机译:随机对照试验中基线协变量的p值不平衡:使用p值的最后手段是什么?赞成与反对辩论
机译:通过模型选择和高维协变量自适应估计Cox模型中的基线危害函数